Sanofi’s €320m bet pays off as radiopharmaceutical shows benefit in GEP-NETs
Sanofi acquired commercialisation rights for AlphaMedix from Orana Med in September 2024.
09 October 2025
09 October 2025
Sanofi acquired commercialisation rights for AlphaMedix from Orana Med in September 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.